(Dealbreaker.com) Once upon a time, Martin Shkreli was an investment professional who made a nice chunk of change by doing things like lobbying the Food and Drug Administration “not to approve certain drugs made by companies whose stock he was shorting.” Then one day he realized that while running a hedge fund provided a nice standard of living, he stood to make some real money…..
EX-Hedge Fund Manager Turned Pharmaceutical CEO Charges $750 Today for Life-Saving Drug That Cost $13.50 Yesterday
This entry was posted in Syndicated. Bookmark the permalink.
